February 20, 2017 / 7:01 AM / 6 months ago

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

Feb 20 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd :

* Says co's controlling bio-pharmaceuticals unit receives GMP certificate from Shanghai Food and Drug Administration

* Certificate is issued to plants of APIs (paclitaxel and docetaxel) in the unit and the valid period is until Jan. 21, 2022

Source text in Chinese: goo.gl/vmKI18

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below